{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:38:15Z","timestamp":1790030295798,"version":"4.0.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22327-1","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:02:50Z","timestamp":1762160570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["An impaired glycolysis induces ATP deficiency and reduced cell respiration in stem cells of patients with autism spectrum disorders"],"prefix":"10.1038","volume":"15","author":[{"given":"Francois","family":"F\u00e9ron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Caillol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Fourel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Leimkuhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Iranzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Gepner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Guiraudie-Capraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"22327_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s40474-014-0033-3","volume":"2","author":"E-M Hahler","year":"2015","unstructured":"Hahler, E.-M. & Elsabbagh, M. Autism: A global perspective. Curr. Dev. Disord. Rep. 2, 58\u201364 (2015).","journal-title":"Curr. Dev. Disord. Rep."},{"key":"22327_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1089\/scd.2009.0267","volume":"19","author":"B Delorme","year":"2010","unstructured":"Delorme, B. et al. The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties. Stem Cells Dev. 19, 853\u2013866 (2010).","journal-title":"Stem Cells Dev."},{"key":"22327_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/mp.2015.106","volume":"21","author":"F F\u00e9ron","year":"2016","unstructured":"F\u00e9ron, F. et al. Olfactory stem cells reveal MOCOS as a new player in autism spectrum disorders. Mol. Psychiatry 21, 1215\u20131224 (2016).","journal-title":"Mol. Psychiatry"},{"key":"22327_CR4","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/s41380-020-0728-2","volume":"26","author":"P Rontani","year":"2021","unstructured":"Rontani, P. et al. Impaired expression of the COSMOC\/MOCOS gene unit in ASD patient stem cells. Mol. Psychiatry 26, 1606\u20131618 (2021).","journal-title":"Mol. Psychiatry"},{"key":"22327_CR5","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.bbamcr.2012.02.007","volume":"1823","author":"RR Mendel","year":"2012","unstructured":"Mendel, R. R. & Kruse, T. Cell biology of molybdenum in plants and humans. Biochim. Biophys. Acta (BBA) Mol. Cell Res. 1823, 1568\u20131579 (2012).","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Res."},{"key":"22327_CR6","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.3390\/molecules28196998","volume":"28","author":"RR Mendel","year":"2023","unstructured":"Mendel, R. R. & Schwarz, G. The history of animal and plant sulfite oxidase\u2014a personal view. Molecules 28, 6998 (2023).","journal-title":"Molecules"},{"key":"22327_CR7","doi-asserted-by":"publisher","first-page":"101882","DOI":"10.1016\/j.redox.2021.101882","volume":"41","author":"M Bortolotti","year":"2021","unstructured":"Bortolotti, M., Polito, L., Battelli, M. G. & Bolognesi, A. Xanthine oxidoreductase: One enzyme for multiple physiological tasks. Redox Biol. 41, 101882 (2021).","journal-title":"Redox Biol."},{"key":"22327_CR8","doi-asserted-by":"publisher","first-page":"105306","DOI":"10.1016\/j.jbc.2023.105306","volume":"299","author":"MA Struwe","year":"2023","unstructured":"Struwe, M. A., Scheidig, A. J. & Clement, B. The mitochondrial amidoxime reducing component\u2014from prodrug-activation mechanism to drug-metabolizing enzyme and onward to drug target. J. Biol. Chem. 299, 105306 (2023).","journal-title":"J. Biol. Chem."},{"key":"22327_CR9","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.2174\/1570159X21666221121095618","volume":"21","author":"SU Nabi","year":"2023","unstructured":"Nabi, S. U. et al. Treatment of autism spectrum disorders by mitochondrial-targeted drug: Future of neurological diseases therapeutics. Curr. Neuropharmacol. 21, 1042\u20131064 (2023).","journal-title":"Curr. Neuropharmacol."},{"key":"22327_CR10","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/jama.2010.1706","volume":"304","author":"C Giulivi","year":"2010","unstructured":"Giulivi, C. et al. Mitochondrial dysfunction in autism. JAMA 304, 2389\u20132396 (2010).","journal-title":"JAMA"},{"key":"22327_CR11","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/nar\/gkg282","volume":"31","author":"L Levinger","year":"2003","unstructured":"Levinger, L., Gieg\u00e9, R. & Florentz, C. Pathology-related substitutions in human mitochondrial tRNAIle reduce precursor 3\u2032 end processing efficiency in vitro. Nucleic Acids Res. 31, 1904\u20131912 (2003).","journal-title":"Nucleic Acids Res."},{"key":"22327_CR12","doi-asserted-by":"publisher","first-page":"e3815","DOI":"10.1371\/journal.pone.0003815","volume":"3","author":"JR Weissman","year":"2008","unstructured":"Weissman, J. R. et al. Mitochondrial disease in autism spectrum disorder patients: A cohort analysis. PLoS ONE 3, e3815 (2008).","journal-title":"PLoS ONE"},{"key":"22327_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s10803-017-3329-4","volume":"48","author":"E Napoli","year":"2018","unstructured":"Napoli, E. et al. Array-CGH analysis in a cohort of phenotypically well-characterized individuals with \u201cessential\u201d autism spectrum disorders. J. Autism Dev. Disord. 48, 442\u2013449 (2018).","journal-title":"J. Autism Dev. Disord."},{"key":"22327_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1469-1809.2012.00736.x","volume":"77","author":"A Hadjixenofontos","year":"2013","unstructured":"Hadjixenofontos, A. et al. Evaluating mitochondrial DNA variation in autism spectrum disorders. Ann. Hum. Genet. 77, 9\u201321 (2013).","journal-title":"Ann. Hum. Genet."},{"key":"22327_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ddrr.112","volume":"16","author":"RH Haas","year":"2010","unstructured":"Haas, R. H. Autism and mitochondrial disease. Dev. Disabil. Res. Rev. 16, 144\u2013153 (2010).","journal-title":"Dev. Disabil. Res. Rev."},{"key":"22327_CR16","doi-asserted-by":"publisher","first-page":"e4415","DOI":"10.1371\/journal.pone.0004415","volume":"4","author":"N Boddaert","year":"2009","unstructured":"Boddaert, N. et al. MRI findings in 77 children with non-syndromic autistic disorder. PLoS ONE 4, e4415 (2009).","journal-title":"PLoS ONE"},{"key":"22327_CR17","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1038\/tp.2013.68","volume":"3","author":"F Gu","year":"2013","unstructured":"Gu, F. et al. Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl. Psychiatry 3, e299\u2013e299 (2013).","journal-title":"Transl. Psychiatry"},{"key":"22327_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2040-2392-3-12","volume":"3","author":"A Anitha","year":"2012","unstructured":"Anitha, A. et al. Brain region-specific altered expression and association of mitochondria-related genes in autism. Mol. Autism 3, 12 (2012).","journal-title":"Mol. Autism"},{"key":"22327_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/bpa.12002","volume":"23","author":"A Anitha","year":"2012","unstructured":"Anitha, A. et al. Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol. 23, 294\u2013302 (2012).","journal-title":"Brain Pathol."},{"key":"22327_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/mp.2010.136","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol, D. A. & Frye, R. E. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 17, 290\u2013314 (2012).","journal-title":"Mol. Psychiatry"},{"key":"22327_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","volume":"10","author":"A Suomalainen","year":"2011","unstructured":"Suomalainen, A. et al. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. Lancet Neurol. 10, 806\u2013818 (2011).","journal-title":"Lancet Neurol."},{"key":"22327_CR22","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.10596","volume":"53","author":"PA Filipek","year":"2003","unstructured":"Filipek, P. A. et al. Mitochondrial dysfunction in autistic patients with 15q inverted duplication. Ann. Neurol. 53, 801\u2013804 (2003).","journal-title":"Ann. Neurol."},{"key":"22327_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.90.15_supplement.P3.313","volume-title":"Effect of a Combination of Carnitine, Coenzyme Q10 and Alpha-Lipoic Acid (MitoCocktail) on Mitochondrial Function and Neurobehavioral Performance in Children with Autism Spectrum Disorder","author":"A Legido","year":"2018","unstructured":"Legido, A. Effect of a Combination of Carnitine, Coenzyme Q10 and Alpha-Lipoic Acid (MitoCocktail) on Mitochondrial Function and Neurobehavioral Performance in Children with Autism Spectrum Disorder (IMFAR, 2018)."},{"key":"22327_CR24","doi-asserted-by":"publisher","first-page":"e532640","DOI":"10.1155\/2009\/532640","volume":"2009","author":"JB Adams","year":"2009","unstructured":"Adams, J. B. et al. The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. J. Toxicol. 2009, e532640 (2009).","journal-title":"J. Toxicol."},{"key":"22327_CR25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S0891-5849(02)01356-4","volume":"34","author":"C Borr\u00e1s","year":"2003","unstructured":"Borr\u00e1s, C. et al. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic. Biol. Med. 34, 546\u2013552 (2003).","journal-title":"Free Radic. Biol. Med."},{"key":"22327_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF01837894","volume":"15","author":"M Coleman","year":"1985","unstructured":"Coleman, M. & Blass, J. P. Autism and lactic acidosis. J. Autism Dev. Disord. 15, 1\u20138 (1985).","journal-title":"J. Autism Dev. Disord."},{"key":"22327_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mito.2018.03.002","volume":"46","author":"G Ramirez-Barbieri","year":"2019","unstructured":"Ramirez-Barbieri, G. et al. Alloreactivity and allorecognition of syngeneic and allogeneic mitochondria. Mitochondrion 46, 103\u2013115 (2019).","journal-title":"Mitochondrion"},{"key":"22327_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.mito.2016.07.003","volume":"30","author":"M Picard","year":"2016","unstructured":"Picard, M., Wallace, D. C. & Burelle, Y. The rise of mitochondria in medicine. Mitochondrion 30, 105\u2013116 (2016).","journal-title":"Mitochondrion"},{"key":"22327_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0009-8981(94)90243-7","volume":"229","author":"A L\u00e1szl\u00f3","year":"1994","unstructured":"L\u00e1szl\u00f3, A., Horv\u00e1th, E., Eck, E. & Fekete, M. Serum serotonin, lactate and pyruvate levels in infantile autistic children. Clin. Chim. Acta 229, 205\u2013207 (1994).","journal-title":"Clin. Chim. Acta"},{"key":"22327_CR30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1023\/A:1025071014191","volume":"33","author":"GL Arnold","year":"2003","unstructured":"Arnold, G. L., Hyman, S. L., Mooney, R. A. & Kirby, R. S. Plasma amino acids profiles in children with autism: Potential risk of nutritional deficiencies. J. Autism Dev. Disord. 33, 449\u2013454 (2003).","journal-title":"J. Autism Dev. Disord."},{"key":"22327_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamapsychiatry.2014.179","volume":"71","author":"S Goh","year":"2014","unstructured":"Goh, S., Dong, Z., Zhang, Y., DiMauro, S. & Peterson, B. S. Brain imaging evidence that mitochondrial dysfunction is a neurobiological subtype of autism spectrum disorder. JAMA Psychiat. 71, 665\u2013671 (2014).","journal-title":"JAMA Psychiat."},{"key":"22327_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1742-2094-8-142","volume":"8","author":"AK El-Ansary","year":"2011","unstructured":"El-Ansary, A. K., Ben Bacha, A. G. & Al-Ayadhi, L. Y. Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia. J. Neuroinflamm. 8, 142 (2011).","journal-title":"J. Neuroinflamm."},{"key":"22327_CR33","doi-asserted-by":"publisher","first-page":"875182","DOI":"10.3389\/fgene.2022.875182","volume":"13","author":"S Mellone","year":"2022","unstructured":"Mellone, S. et al. The usefulness of a targeted next generation sequencing gene panel in providing molecular diagnosis to patients with a broad spectrum of neurodevelopmental disorders. Front. Genet. 13, 875182 (2022).","journal-title":"Front. Genet."},{"key":"22327_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00439-021-02404-x","volume":"141","author":"A Mir","year":"2022","unstructured":"Mir, A. et al. SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population. Hum. Genet. 141, 81\u201399 (2022).","journal-title":"Hum. Genet."},{"key":"22327_CR35","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/brain\/awaa051","volume":"143","author":"JA L\u00f3pez-Rivera","year":"2020","unstructured":"L\u00f3pez-Rivera, J. A. et al. A catalogue of new incidence estimates of monogenic neurodevelopmental disorders caused by de novo variants. Brain 143, 1099\u20131105 (2020).","journal-title":"Brain"},{"key":"22327_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.yebeh.2015.03.017","volume":"47","author":"BH Lee","year":"2015","unstructured":"Lee, B. H., Smith, T. & Paciorkowski, A. R. Autism spectrum disorder and epilepsy: disorders with a shared biology. Epilepsy Behav. 47, 191\u2013201 (2015).","journal-title":"Epilepsy Behav."},{"key":"22327_CR37","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/jmedgenet-2014-102554","volume":"51","author":"C Redin","year":"2014","unstructured":"Redin, C. et al. Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing. J. Med. Genet. 51, 724\u2013736 (2014).","journal-title":"J. Med. Genet."},{"key":"22327_CR38","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.ajhg.2017.03.009","volume":"100","author":"M Srour","year":"2017","unstructured":"Srour, M. et al. Dysfunction of the cerebral glucose transporter SLC45A1 in individuals with intellectual disability and epilepsy. Am. J. Hum. Genet. 100, 824\u2013830 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"22327_CR39","doi-asserted-by":"publisher","first-page":"107277","DOI":"10.1016\/j.yebeh.2020.107277","volume":"111","author":"A Meyyazhagan","year":"2020","unstructured":"Meyyazhagan, A. et al. Scrutinizing the molecular, biochemical, and cytogenetic attributes in subjects with Rett syndrome (RTT) and their mothers. Epilepsy Behav. 111, 107277 (2020).","journal-title":"Epilepsy Behav."},{"key":"22327_CR40","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202306.0050.v1","author":"F Stancioiu","year":"2023","unstructured":"Stancioiu, F., Bogdan, R. & Dumitrescu, R. Neuron-specific enolase (NSE) as a biomarker for autistic spectrum disease (ASD). Life https:\/\/doi.org\/10.20944\/preprints202306.0050.v1 (2023).","journal-title":"Life"},{"key":"22327_CR41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.bbi.2019.12.002","volume":"84","author":"A Ramirez-Celis","year":"2020","unstructured":"Ramirez-Celis, A., Edmiston, E., Schauer, J., Vu, T. & Van de Water, J. Peptides of neuron specific enolase as potential ASD biomarkers: From discovery to epitope mapping. Brain Behav. Immun. 84, 200\u2013208 (2020).","journal-title":"Brain Behav. Immun."},{"key":"22327_CR42","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00431-014-2311-9","volume":"173","author":"Y Wang","year":"2014","unstructured":"Wang, Y. et al. Hypermethylation of the enolase gene (ENO2) in autism. Eur. J. Pediatr. 173, 1233\u20131244 (2014).","journal-title":"Eur. J. Pediatr."},{"key":"22327_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1515\/tnsci-2016-0002","volume":"7","author":"M Lv","year":"2016","unstructured":"Lv, M. et al. The neonatal levels of TSB, NSE and CK-BB in autism spectrum disorder from Southern China. Transl. Neurosci. 7, 6\u201311 (2016).","journal-title":"Transl. Neurosci."},{"key":"22327_CR44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.9758\/cpn.2020.18.2.270","volume":"18","author":"H Ayayd\u0131n","year":"2020","unstructured":"Ayayd\u0131n, H. et al. High serum levels of serum 100 beta protein, neuron-specific enolase, tau, active caspase-3, M30 and M65 in children with autism spectrum disorders. Clin. Psychopharmacol. Neurosci. 18, 270\u2013278 (2020).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"22327_CR45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijdevneu.2017.06.011","volume":"61","author":"E Esnafoglu","year":"2017","unstructured":"Esnafoglu, E. et al. Evaluation of serum Neuron-specific enolase, S100B, myelin basic protein and glial fibrilliary acidic protein as brain specific proteins in children with autism spectrum disorder. Int. J. Dev. Neurosci. 61, 86\u201391 (2017).","journal-title":"Int. J. Dev. Neurosci."},{"key":"22327_CR46","doi-asserted-by":"publisher","first-page":"788779","DOI":"10.3389\/fpsyt.2021.788779","volume":"12","author":"AA Harutyunyan","year":"2021","unstructured":"Harutyunyan, A. A., Harutyunyan, H. A. & Yenkoyan, K. B. Novel Probable glance at inflammatory scenario development in autistic pathology. Front. Psychiatry 12, 788779 (2021).","journal-title":"Front. Psychiatry"},{"key":"22327_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4331\/wjbc.v10.i1.7","volume":"10","author":"C Demarquoy","year":"2019","unstructured":"Demarquoy, C. & Demarquoy, J. Autism and carnitine: A possible link. World J. Biol. Chem. 10, 7\u201316 (2019).","journal-title":"World J. Biol. Chem."},{"key":"22327_CR48","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10803-004-5283-1","volume":"34","author":"PA Filipek","year":"2004","unstructured":"Filipek, P. A., Juranek, J., Nguyen, M. T., Cummings, C. & Gargus, J. J. Relative carnitine deficiency in autism. J. Autism Dev. Disord. 34, 615\u2013623 (2004).","journal-title":"J. Autism Dev. Disord."},{"key":"22327_CR49","first-page":"609705","volume":"2013","author":"RE Frye","year":"2013","unstructured":"Frye, R. E. et al. Effectiveness of methylcobalamin and folinic acid treatment on adaptive behavior in children with autistic disorder is related to glutathione redox status. Autism Res. Treat. 2013, 609705 (2013).","journal-title":"Autism Res. Treat."},{"key":"22327_CR50","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1093\/hmg\/ddr363","volume":"20","author":"PBS Celestino-Soper","year":"2011","unstructured":"Celestino-Soper, P. B. S. et al. Use of array CGH to detect exonic copy number variants throughout the genome in autism families detects a novel deletion in TMLHE. Hum. Mol. Genet. 20, 4360\u20134370 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"22327_CR51","doi-asserted-by":"publisher","first-page":"7974","DOI":"10.1073\/pnas.1120210109","volume":"109","author":"PBS Celestino-Soper","year":"2012","unstructured":"Celestino-Soper, P. B. S. et al. A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc. Natl. Acad. Sci. U. S. A. 109, 7974\u20137981 (2012).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"22327_CR52","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2016.11.013","volume":"167","author":"DC Tarlungeanu","year":"2016","unstructured":"Tarlungeanu, D. C. et al. Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder. Cell 167, 1481-1494.e18 (2016).","journal-title":"Cell"},{"key":"22327_CR53","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.3390\/molecules24234262","volume":"24","author":"M Malaguarnera","year":"2019","unstructured":"Malaguarnera, M. & Cauli, O. Effects of l-carnitine in patients with autism spectrum disorders: Review of clinical studies. Molecules 24, 4262 (2019).","journal-title":"Molecules"},{"key":"22327_CR54","doi-asserted-by":"publisher","first-page":"PI15","DOI":"10.12659\/MSM.881792","volume":"17","author":"DA Geier","year":"2011","unstructured":"Geier, D. A. et al. A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders. Med. Sci. Monit. 17, PI15-23 (2011).","journal-title":"Med. Sci. Monit."},{"key":"22327_CR55","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.rasd.2012.07.006","volume":"7","author":"SF Fahmy","year":"2013","unstructured":"Fahmy, S. F., El-hamamsy, M. H., Zaki, O. K. & Badary, O. A. l-Carnitine supplementation improves the behavioral symptoms in autistic children. Res. Autism Spectrum Disord. 7, 159\u2013166 (2013).","journal-title":"Res. Autism Spectrum Disord."},{"key":"22327_CR56","doi-asserted-by":"publisher","first-page":"2333794X1983069","DOI":"10.1177\/2333794X19830696","volume":"6","author":"RP Goin-Kochel","year":"2019","unstructured":"Goin-Kochel, R. P. et al. Side effects and behavioral outcomes following high-dose carnitine supplementation among young males with autism spectrum disorder: A pilot study. Glob. Pediatric Health 6, 2333794X19830696 (2019).","journal-title":"Glob. Pediatric Health"},{"key":"22327_CR57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg, O. On the origin of cancer cells. Science 123, 309\u2013314 (1956).","journal-title":"Science"},{"key":"22327_CR58","doi-asserted-by":"publisher","first-page":"753","DOI":"10.21037\/atm-22-1074","volume":"10","author":"M Ilieva","year":"2022","unstructured":"Ilieva, M. & Uchida, S. Functional roles of epitranscriptomic marks in the cardiovascular system and disease: a narrative review. Ann. Transl. Med. 10, 753 (2022).","journal-title":"Ann. Transl. Med."},{"key":"22327_CR59","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1096\/fj.201601004R","volume":"31","author":"S Rose","year":"2017","unstructured":"Rose, S. et al. Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study. FASEB J. 31, 904\u2013909 (2017).","journal-title":"FASEB J."},{"key":"22327_CR60","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/088307380201700607","volume":"17","author":"JJ Filiano","year":"2002","unstructured":"Filiano, J. J., Goldenthal, M. J., Harker Rhodes, C. & Marin-Garcia, J. Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome. J. Child. Neurol. 17, 435\u2013439 (2002).","journal-title":"J. Child. Neurol."},{"key":"22327_CR61","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/0883073809342128","volume":"25","author":"J Shoffner","year":"2010","unstructured":"Shoffner, J. et al. Fever plus mitochondrial disease could be risk factors for autistic regression. J. Child. Neurol. 25, 429\u2013434 (2010).","journal-title":"J. Child. Neurol."},{"key":"22327_CR62","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s11011-017-0085-2","volume":"32","author":"AM Khemakhem","year":"2017","unstructured":"Khemakhem, A. M., Frye, R. E., El-Ansary, A., Al-Ayadhi, L. & Bacha, A. B. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers. Metab. Brain Dis. 32, 1983\u20131997 (2017).","journal-title":"Metab. Brain Dis."},{"key":"22327_CR63","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1471-4159.2011.07189.x","volume":"117","author":"A Chauhan","year":"2011","unstructured":"Chauhan, A. et al. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J. Neurochem. 117, 209\u2013220 (2011).","journal-title":"J. Neurochem."},{"key":"22327_CR64","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.3390\/ijms21093266","volume":"21","author":"Y Ahn","year":"2020","unstructured":"Ahn, Y. et al. Aberrant mitochondrial morphology and function in the BTBR mouse model of autism is improved by two weeks of ketogenic diet. Int. J. Mol. Sci. 21, 3266 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"22327_CR65","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.freeradbiomed.2020.02.023","volume":"152","author":"A Pecorelli","year":"2020","unstructured":"Pecorelli, A., Cervellati, C., Cordone, V., Hayek, J. & Valacchi, G. Compromised immune\/inflammatory responses in Rett syndrome. Free Radic. Biol. Med. 152, 100\u2013106 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"22327_CR66","doi-asserted-by":"publisher","first-page":"e85436","DOI":"10.1371\/journal.pone.0085436","volume":"9","author":"S Rose","year":"2014","unstructured":"Rose, S. et al. Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort. PLoS ONE 9, e85436 (2014).","journal-title":"PLoS ONE"},{"key":"22327_CR67","doi-asserted-by":"publisher","first-page":"e573701","DOI":"10.1155\/2015\/573701","volume":"2015","author":"S Rose","year":"2015","unstructured":"Rose, S., Wynne, R., Frye, R. E., Melnyk, S. & James, S. J. Increased susceptibility to ethylmercury-induced mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines. J. Toxicol. 2015, e573701 (2015).","journal-title":"J. Toxicol."},{"key":"22327_CR68","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fpsyt.2019.00071","volume":"10","author":"H Jyonouchi","year":"2019","unstructured":"Jyonouchi, H., Geng, L., Rose, S., Bennuri, S. C. & Frye, R. E. Variations in mitochondrial respiration differ in IL-1\u00df\/IL-10 ratio based subgroups in autism spectrum disorders. Front. Psychiatry 10, 71 (2019).","journal-title":"Front. Psychiatry"},{"key":"22327_CR69","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3390\/cimb43030157","volume":"43","author":"H Hassan","year":"2021","unstructured":"Hassan, H., Zakaria, F., Makpol, S. & Karim, N. A. A link between mitochondrial dysregulation and idiopathic autism spectrum disorder (ASD): Alterations in mitochondrial respiratory capacity and membrane potential. Curr. Issues Mol. Biol. 43, 2238\u20132252 (2021).","journal-title":"Curr. Issues Mol. Biol."},{"key":"22327_CR70","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2174\/1568026621666210521142131","volume":"21","author":"M Gevezova","year":"2021","unstructured":"Gevezova, M. et al. Cellular bioenergetic and metabolic changes in patients with autism spectrum disorder. Curr. Top. Med. Chem. 21, 985\u2013994 (2021).","journal-title":"Curr. Top. Med. Chem."},{"key":"22327_CR71","doi-asserted-by":"publisher","first-page":"586209","DOI":"10.3389\/fnmol.2020.586209","volume":"13","author":"S Behl","year":"2020","unstructured":"Behl, S., Mehta, S. & Pandey, M. K. Abnormal levels of metal micronutrients and autism spectrum disorder: A perspective review. Front. Mol. Neurosci. 13, 586209 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"22327_CR72","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neubiorev.2021.07.029","volume":"129","author":"J Baj","year":"2021","unstructured":"Baj, J. et al. Autism spectrum disorder: Trace elements imbalances and the pathogenesis and severity of autistic symptoms. Neurosci. Biobehav. Rev. 129, 117\u2013132 (2021).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"22327_CR73","doi-asserted-by":"publisher","first-page":"114561","DOI":"10.1016\/j.ecoenv.2023.114561","volume":"251","author":"SM Awadh","year":"2023","unstructured":"Awadh, S. M., Yaseen, Z. M. & Al-Suwaiyan, M. S. The role of environmental trace element toxicants on autism: A medical biogeochemistry perspective. Ecotoxicol. Environ. Saf. 251, 114561 (2023).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"22327_CR74","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.envres.2019.01.060","volume":"171","author":"Q Zhai","year":"2019","unstructured":"Zhai, Q. et al. Disturbance of trace element and gut microbiota profiles as indicators of autism spectrum disorder: A pilot study of Chinese children. Environ. Res. 171, 501\u2013509 (2019).","journal-title":"Environ. Res."},{"key":"22327_CR75","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nchembio.72","volume":"4","author":"B-E Kim","year":"2008","unstructured":"Kim, B.-E., Nevitt, T. & Thiele, D. J. Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol. 4, 176\u2013185 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"22327_CR76","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1074\/jbc.R800055200","volume":"284","author":"ML Turski","year":"2009","unstructured":"Turski, M. L. & Thiele, D. J. New roles for copper metabolism in cell proliferation, signaling, and disease. J. Biol. Chem. 284, 717\u2013721 (2009).","journal-title":"J. Biol. Chem."},{"key":"22327_CR77","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fphys.2016.00594","volume":"7","author":"P Mondola","year":"2016","unstructured":"Mondola, P., Damiano, S., Sasso, A. & Santillo, M. The Cu, Zn superoxide dismutase: Not only a dismutase enzyme. Front. Physiol. 7, 594 (2016).","journal-title":"Front. Physiol."},{"key":"22327_CR78","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.chembiol.2017.08.005","volume":"24","author":"C Valli\u00e8res","year":"2017","unstructured":"Valli\u00e8res, C., Holland, S. L. & Avery, S. V. Mitochondrial ferredoxin determines vulnerability of cells to copper excess. Cell Chem. Biol. 24, 1228-1237.e3 (2017).","journal-title":"Cell Chem. Biol."},{"key":"22327_CR79","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1515\/hsz-2020-0117","volume":"401","author":"R Lill","year":"2020","unstructured":"Lill, R. From the discovery to molecular understanding of cellular iron-sulfur protein biogenesis. Biol. Chem. 401, 855\u2013876 (2020).","journal-title":"Biol. Chem."},{"key":"22327_CR80","doi-asserted-by":"publisher","first-page":"39872","DOI":"10.1074\/jbc.M102781200","volume":"276","author":"MA Johnson","year":"2001","unstructured":"Johnson, M. A., Macdonald, T. L., Mannick, J. B., Conaway, M. R. & Gaston, B. Accelerated S-nitrosothiol breakdown by amyotrophic lateral sclerosis mutant copper, zinc-superoxide dismutase. J. Biol. Chem. 276, 39872\u201339878 (2001).","journal-title":"J. Biol. Chem."},{"key":"22327_CR81","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/biom13010144","volume":"13","author":"MO Ogunkola","year":"2023","unstructured":"Ogunkola, M. O., Guiraudie-Capraz, G., Feron, F. & Leimk\u00fchler, S. The human mercaptopyruvate sulfurtransferase TUM1 is involved in moco biosynthesis, cytosolic tRNA thiolation and cellular bioenergetics in human embryonic kidney cells. Biomolecules 13, 144 (2023).","journal-title":"Biomolecules"},{"key":"22327_CR82","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.acthis.2017.03.001","volume":"119","author":"AJ Valente","year":"2017","unstructured":"Valente, A. J., Maddalena, L. A., Robb, E. L., Moradi, F. & Stuart, J. A. A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. Acta Histochem. 119, 315\u2013326 (2017).","journal-title":"Acta Histochem."},{"key":"22327_CR83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-6890-9_2","volume-title":"Techniques to Investigate Mitochondrial Function in Neurons","author":"RA Merrill","year":"2017","unstructured":"Merrill, R. A., Flippo, K. H. & Strack, S. Measuring mitochondrial shape with ImageJ. In Techniques to Investigate Mitochondrial Function in Neurons (eds Strack, S. & Usachev, Y. M.) 31\u201348 (Springer, 2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22327-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22327-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22327-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:02:42Z","timestamp":1762549362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22327-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22327"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22327-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5261641\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38353"}}